Leadership In Controlled Gene Expression

Overview

The Tet Technology is the most widely used technology to control gene expression as documented by:

  • More than 12,000 scientific publications as of 03/2015
  • More than 1,500 accounts at Clontech alone, serving both academic and commercial customers
  • Since 1996, more than 150 organisations have licensed the Tet Technology
  • 17 out of the top 20 pharmaceutical companies based on their netsales in 2006 are currently licensees

IP Portfolio

  • The TET IP Portfolio comprises 22 issued patents organised in 5 patent families
  • The TET IP portfolio relates to  the original and improved versions of transcriptional activators,  silencers, responsive elements and  chromosomal loci for transgenesis
  • The Tet Technology is patent protected in North-America, Europe, Japan and Australia